Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process ..read more

Furthermore, we are delighted to highlight the remarkable achievements made by all AME journals in the CiteScore ranking. Journal of Medical Artificial Intelligence (JMAI) has received its 2022 CiteScore: 3, ranking 146 out of 309 journals in the Medicine (miscellaneous) category ..read more

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspective and insightful view as authors ..read more

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process ..read more

We wish you a very Happy 2024, filled with success, happiness and good health ..read more

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process ..read more

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020. Around 60 AME journals’ peer review systems are now integrated seamlessly into the Publons platform ( ). The partnership was done to recognize our expert peer reviewers spontaneously for their review contribution ..read more

Welcome to Journal of Medical Artificial Intelligence (JMAI). With the mission to promote specific areas of medical artificial intelligence (AI), this journal is dedicated to showcase the latest issues in the field. The study and development of AI has experienced 70 years of development. Although AI developed slowly in the past decades, innovative technologies have propelled advances in AI in recent years. The invention of applications, software and algorithms that helps manipulate a large amount of data produces statistically- and evidence-based results, and their application into the medical ..read more

We wish you a very Happy 2020, filled with success, happiness and good health ..read more

As many as 33 per 100,000 people experience episodes of paroxysmal impairment associated with a range of manifestations that can be motor, sensory, and/or mental and closely mimic and frequently mistaken for epileptic seizures (1). These episodes are termed psychogenic non-epileptic seizures (PNES). The prevalence of PNES episodes is much higher in epilepsy practices, reaching as high as 30% (2). The diagnosis of PNES remains a process of excluding epilepsy and thus leads to an average time from onset of these paroxysms to diagnosis of close to seven years ..read more